Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats
- PMID: 27547013
- PMCID: PMC4970478
- DOI: 10.3748/wjg.v22.i29.6706
Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats
Abstract
Aim: To observe the alterations in gut microbiota in high-fat diet (HFD)-induced diabetes recurrence after duodenal-jejunal bypass (DJB) in rats.
Methods: We assigned HDF- and low-dose streptozotocin-induced diabetic rats into two major groups to receive DJB and sham operation respectively. When the DJB was completed, we used HFD to induce diabetes recurrence. Then, we grouped the DJB-operated rats by blood glucose level into the DJB-remission (DJB-RM) group and the DJB-recurrence (DJB-RC) group. At a sequence of time points after operations, we compared calorie content in the food intake (calorie intake), oral glucose tolerance test, homeostasis model assessment of insulin resistance (HOMA-IR), concentrations of glucagon-like peptide 1 (GLP-1), serum insulin, total bile acids (TBAs) and lipopolysaccharide (LPS) and alterations in colonic microbiota.
Results: The relative abundance of Firmicutes in the control (58.06% ± 11.12%; P < 0.05 vs sham; P < 0.05 vs DJB-RC) and DJB-RM (55.58% ± 6.16%; P < 0.05 vs sham; P < 0.05 vs DJB-RC) groups was higher than that in the sham (29.04% ± 1.36%) and DJB-RC (27.44% ± 2.17%) groups; but the relative abundance of Bacteroidetes was lower (control group: 33.46% ± 10.52%, P < 0.05 vs sham 46.88% ± 2.34%, P < 0.05 vs DJB-RC 47.41% ± 5.67%. DJB-RM group: 34.63% ± 3.37%, P < 0.05 vs sham; P < 0.05 vs DJB-RC). Escherichia coli was higher in the sham (15.72% ± 1.67%, P < 0.05 vs control, P < 0.05 vs DJB-RM) and DJB-RC (16.42% ± 3.00%; P < 0.05 vs control; P < 0.05 vs DJB-RM) groups than in the control (3.58% ± 3.67%) and DJB-RM (4.15% ± 2.76%) groups. Improved HOMA-IR (2.82 ± 0.73, P < 0.05 vs DJB-RC 4.23 ± 0.72), increased TBAs (27803.17 ± 4673.42 ng/mL; P < 0.05 vs DJB-RC 18744.00 ± 3047.26 ng/mL) and decreased LPS (0.12 ± 0.04 ng/mL, P < 0.05 vs DJB-RC 0.19 ± 0.03 ng/mL) were observed the in DJB-RM group; however, these improvements were reversed in the DJB-RC group, with the exception of GLP-1 (DJB-RM vs DJB-RC P > 0.05).
Conclusion: Alterations in gut microbiota may be responsible for the diabetes remission and recurrence after DJB, possibly by influencing serum LPS and TBAs.
Keywords: Diabetes recurrence; Duodenal-jejunal bypass; Gut microbiota; Lipopolysaccharide; Total bile acids.
Figures






Similar articles
-
Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.Obes Surg. 2021 Jan;31(1):327-336. doi: 10.1007/s11695-020-04974-7. Epub 2020 Sep 24. Obes Surg. 2021. PMID: 32974816 Review.
-
Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function.World J Gastroenterol. 2017 May 21;23(19):3468-3479. doi: 10.3748/wjg.v23.i19.3468. World J Gastroenterol. 2017. PMID: 28596682 Free PMC article.
-
Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.Obes Surg. 2015 Oct;25(10):1802-9. doi: 10.1007/s11695-015-1633-7. Obes Surg. 2015. PMID: 25726319
-
Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model.Obes Surg. 2016 Aug;26(8):1890-9. doi: 10.1007/s11695-015-2031-x. Obes Surg. 2016. PMID: 26715331
-
Hepatic abscess as a complication of duodenal-jejunal bypass sleeve system and review of the literature.Surg Obes Relat Dis. 2016 Jun;12(5):e47-e50. doi: 10.1016/j.soard.2016.02.018. Epub 2016 Feb 23. Surg Obes Relat Dis. 2016. PMID: 27317596 Review. No abstract available.
Cited by
-
Duodenal-jejunal bypass ameliorates MASLD in rats by regulating gut microbiota and bile acid metabolism through FXR pathways.Hepatol Commun. 2025 Jan 16;9(2):e0615. doi: 10.1097/HC9.0000000000000615. eCollection 2025 Feb 1. Hepatol Commun. 2025. PMID: 39813598 Free PMC article.
-
Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.Obes Surg. 2021 Jan;31(1):327-336. doi: 10.1007/s11695-020-04974-7. Epub 2020 Sep 24. Obes Surg. 2021. PMID: 32974816 Review.
-
Single-Anastomosis Duodenal Jejunal Bypass Improve Glucose Metabolism by Regulating Gut Microbiota and Short-Chain Fatty Acids in Goto-Kakisaki Rats.Front Microbiol. 2020 Feb 21;11:273. doi: 10.3389/fmicb.2020.00273. eCollection 2020. Front Microbiol. 2020. PMID: 32153548 Free PMC article.
-
Multi-omics Analysis Reveals the Crucial Mediators of DJB in the Treatment of Type 2 Diabetes.Obes Surg. 2023 Jun;33(6):1676-1686. doi: 10.1007/s11695-023-06551-0. Epub 2023 Apr 13. Obes Surg. 2023. PMID: 37052783
-
Metabolic surgery in China: present and future.J Mol Cell Biol. 2021 Jul 7;13(8):594-609. doi: 10.1093/jmcb/mjab039. Online ahead of print. J Mol Cell Biol. 2021. PMID: 34240190 Free PMC article.
References
-
- Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J, Kennedy L, Kashyap SR, Kirwan JP, Rogula T, Kroh M, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258:628–36; discussion 636-7. - PMC - PubMed
-
- Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, Bouchard C, Carlsson B, Karason K, Lönroth H, Näslund I, Sjöström E, Taube M, Wedel H, Svensson PA, Sjöholm K, Carlsson LM. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–2304. - PubMed
-
- Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25:1822–1832. - PubMed
-
- Kashyap SR, Schauer P. Clinical considerations for the management of residual diabetes following bariatric surgery. Diabetes Obes Metab. 2012;14:773–779. - PubMed
-
- Jiménez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, Vidal J. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256:1023–1029. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical